Tech Company Financing Transactions
Sideris Pharmaceuticals Funding Round
Sideris Pharmaceuticals, operating out of Boston, secured $4.5 million from MPM Capital and private investors.
Transaction Overview
Company Name
Announced On
6/30/2015
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Undisclosed
Investors
MPM Capital (Kazumi Shiosaki)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Clarendon St. 54th Floor
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Website
Email Address
Not Recorded
Overview
Sideris Pharmaceuticals is an independent biopharmaceutical company focused on the development of treatments for diseases of iron overload, including conditions involving maintenance transfusion therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Berk
Browse more venture capital transactions:
Prev: 6/30/2015: Cloud Technology Partners venture capital transaction
Next: 6/30/2015: Game Closure venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs